|
2025
|
Invention
|
Galnac compositions for improving sirna bioavailability.
Provided herein, are compositions compr... |
|
|
Invention
|
Modified oligonucleotides.
Disclosed herein are compositions comprising modified oligonucleotide... |
|
|
Invention
|
Treatment of mtres1 related diseases and disorders. Disclosed herein are compositions comprising ... |
|
2024
|
Invention
|
Treatment of cpn1 related diseases and disorders. Disclosed herein are compositions comprising an... |
|
|
Invention
|
Treatment of gpam related diseases and disorders. GPAMGPAM gene mutations that include providing ... |
|
|
Invention
|
Prodrugs of alox-15 inhibitors and methods of using the same.
Described herein are compounds and... |
|
|
Invention
|
Treatment of sos2 related diseases and disorders. Disclosed herein are compositions comprising an... |
|
|
Invention
|
Modified oligonucleotides. Disclosed herein are compositions comprising modified oligonucleotides... |
|
|
Invention
|
Modified oligonucleotides. Disclosed herein are compositions comprising an oligonucleotide that t... |
|
|
Invention
|
Treatment of hgfac related diseases and disorders. Disclosed herein are compositions comprising a... |
|
|
Invention
|
Process to inhibit or eliminate eosinophilic diseases of the airway and related conditions.
Mole... |
|
|
Invention
|
Treatment of mst1 related diseases and disorders. Disclosed herein are compositions comprising an... |
|
|
Invention
|
Treatment of mst1 related diseases and disorders.
Disclosed herein are compositions comprising a... |
|
|
Invention
|
Treatment of fgg related diseases and disorders. Disclosed herein are compositions comprising an ... |
|
|
Invention
|
Treatment of fgg related hearing disorders. Disclosed herein are compositions comprising an oligo... |
|
|
G/S
|
Pharmaceutical preparations for preventing or treating diseases of the cardiovascular system, dis... |
|
2023
|
Invention
|
Treatment of dkk2 related diseases and disorders. Disclosed herein are compositions comprising an... |
|
|
Invention
|
Treatment of mst1 related diseases and disorders. MST1MST1MST1MST1 to a subject. |
|
|
Invention
|
Treatment of mtres1 related diseases and disorders. MTRES1MTRES1 gene mutations that include prov... |
|
|
Invention
|
Small molecule treatment of mtres1 related diseases and disorders. Disclosed herein are compositi... |
|
|
Invention
|
Gene therapy treatment of mtres1 related diseases and disorders. MTRES1MTRES1 gene mutations that... |
|
|
Invention
|
Galnac compositions for improving sirna bioavailability. Provided herein, are compositions compri... |
|
|
Invention
|
Treatment of gpam related diseases and disorders. Metabolic disorders such as liver disorders and... |
|
|
Invention
|
Treatment of ms4a4e related diseases and disorders. MS4A4EMS4A4EMS4A4E mutations that include pro... |
|
|
Invention
|
Compositions and methods for the treatment of angiopoietin like 7 (angptl7) related diseases.
Pr... |
|
|
Invention
|
Compositions and methods for the treatment of angiopoietin like 7 (angptl7) related diseases. Pro... |
|
|
Invention
|
Treatment of hgfac related diseases and disorders.
Disclosed herein are compositions comprising ... |
|
|
Invention
|
Galnac compositions for improving sirna bioavailability |
|
2022
|
Invention
|
Treatment of fgg related diseases and disorders.
Disclosed herein are compositions comprising an... |
|
|
Invention
|
Treatment of thymic stromal lymphopoietin (tslp) related diseases by inhibition of long-form tslp... |
|
|
Invention
|
Treatment of dkk2 related diseases and disorders.
Disclosed herein are compositions comprising a... |
|
|
Invention
|
Treatment of mst1r related diseases and disorders.
Disclosed herein are compositions comprising ... |
|
|
Invention
|
Treatment of mtres1 related diseases and disorders.
Disclosed herein are compositions comprising... |
|
|
Invention
|
Treatment of plin1 related diseases and disorders.
Disclosed herein are compositions comprising ... |
|
|
Invention
|
Treatment of angptl4 related diseases.
Provided are compositions comprising an oligonucleotide t... |
|
|
Invention
|
Modulation of coasy expression.
Provided herein are specific inhibitors, compositions, methods a... |
|
2021
|
Invention
|
Treatment of sos2 related diseases and disorders.
Disclosed herein are compositions comprising a... |
|
2018
|
G/S
|
Pharmaceutical research in connection with human genetics and programmable biology; pharmaceutica... |
